Structure and function of the glycoprotein Ib-IX-V complex

Current Opinion in Hematology

Volumn 4, Issue 5, 1997, Pages 323-329

  López, José A ^a   Dong, Jing Fei ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN IB; THROMBIN; THROMBIN RECEPTOR; THROMBOCYTE RECEPTOR; VON WILLEBRAND FACTOR;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL INJURY; CELL MEMBRANE; CORONARY ARTERY; CYTOSKELETON; HUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM; WOUND HEALING;

EID: 0030774041     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199704050-00005     Document Type: Review

References (67)

1. Berndt MC, Gregory C, Kabral A, Zola H, Fournier D, Castaldi PA: Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane. Eur J Biochem 1985, 151:637-649.
2. López JA: The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrinolysis 1994, 5:97-119.
3. Modderman PW, Admiraal LG, Sonnenberg A, von dem Borne AEGK: Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane. J Biol Chem 1992, 267:364-369.
4. López JA, Weisman S, Sanan DA, Sin T, Chambers M, Li CO: Glycoprotein (GP) Ibβ Is the critical subunit linking GP Ibα and GP IX in the GP Ib-IX complex: analysis of partial complexes. J Biol Chem 1994, 269:23716-23721.
5. Li CQ, Dong J, Lanza F, Sanan DA, Sae-Tung G, López JA: Expression of platelet glycoprotein (GP) V in heterologous cells and evidence for its association with GP Ibα in forming a GP Ib-IX-V complex on the cell surface. J Biol Chem 1995, 270:16302-16307.
6. Andrews RK, Kroll MH, Ward CM, Rose JW, Scarborough RM, Smith AI, López JA, Berndt MC: Binding of a novel 50-kDa alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex: effect on platelet aggregation and glycoprotein Ib-mediated platelet activation. Biochemistry 1996, 35:12629-12639. This manuscript contains several items of interest, including the amino acid sequences of two C-type lectins, CHH-A and CHH-B, from the venom of the timber rattlesnake, Crotalus horridus, and comparison of these sequences to other pit viper C-lectin sequences. In addition, the authors show that although several of these proteins bind GP Ibα and block vWf binding, they do not bind to the same site. Other points of interest are discussed in the text.
7. Harmon JT, Jamieson GA: Thrombin binds to a high-affinity ≈ 900 000-dalton site on human platelets. Biochemistry 1985, 24:58-64.
8. López JA, Chung DW, Fujikawa K, Hagen FS, Papayannopoulou T, Roth GJ: Cloning of the a chain of human platelet glycoprotein Ib: a transmembrane protein with homology to leucine-rich α2-glycoprotein. Proc Natl Acad Sci U S A 1987, 84:5615-5619.
9. López JA, Chung DW, Fujikawa K, Hagen FS, Davie EW, Roth GJ: The α and β chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence. Proc Natl Acad Sci U S A 1988, 85:2135-2139.
10. Mickey MJ, Williams SA, Roth GJ: Human platelet glycoprotein IX: an adhesive prototype of leucine-rich glycoproteins with flank-center flank structures. Proc Natl Acad Sci U S A 1989, 86:6773-6777.
11. Lanza F, Morales M, de La Salle C, Cazenave J-P, Clemetson KJ, Shimomura T, Phillips DR: Cloning and characterization of the gene encoding the human platelet glycoprotein V: a member of the leucinerich glycoprotein family cleaved during thrombin-induced platelet activation. J Biol Chem 1993, 268:20801-20807.
12. Kobe B, Deisenhofer J: Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature 1993, 366:751-756.
13. Kobe B, Deisenhofer J: A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature 1995, 374:183-186.
14. Andrews RK, López JA, Berndt MC: Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol 1997, 29:91-105. This review explores numerous facets of the interaction between the GP Ib-IX-V complex and vWF and discusses several interesting possibilities for how the interaction takes place. The use of tyrosine sulfation in other adhesion systems is also discussed.
15. 2. Because they used several methods to immobilize vWf, the authors argued that immobilization does not produce a specific conformational change that allows GP Ib-IX-V binding.
16. Savage B, Saldivar E, Ruggeri ZM: Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996, 84:289-297. Elegant demonstration of the roles of fibrinogen and vWf in platelet adhesion under shear, and of the cooperation between the platelet GP Ib-IX-V and GP IIb-IIIa in this process.
17. Wu YP, van Breugel HH, Lankhof H, Wise RJ, Handin RI, de Groot PG, Sixma JJ: Platelet adhesion to multimeric and dimeric von Willebrand factor and to collagen type III preincubated with von Willebrand factor. Arterioscler Thromb Vasc Biol 1996, 16:611-620.
18. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL: Platelets and shear stress. Blood 1996, 88:1525-1541. A comprehensive review of all aspects of the effect of shear on platelets, including shear-induced platelet aggregation, shear-induced adhesion, signal transduction, and the clinical consequences of these processes. The authors describe the use of the cone-plate viscometer to model blood rheology.
19. Berndt MC, Ward CM, Booth WJ, Castaldi PA, Mazurov AV, Andrews RK: Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence In von Willebrand factor: mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry 1992, 31:11144-11151.
20. Dong J-F, Li CO, López JA: Tyrosine sulfation of the GP Ib-IX complex: identification of sulfated residues and effect on ligand binding. Biochemistry 1994, 33:13946-13953.
21. Ward CM, Andrews RK, Smith AI, Berndt MC: Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibα: identification of the sulfated tryosine/anionlc sequence Tyr-276-Glu-282 of glycoprotein Ibα as a binding site for von Willebrand factor and α-thrombin. Biochemistry 1996, 35:4929-4938. The authors describe the use of proteases to map the epitopes of inhibitory monoclonal antibodies to the N-terminus of GP Ibα, including the novel metalloprotease mocarhagin, which cleaves within the GP Ibα anionic sulfated region. The presence of sulfate is confirmed by mass spectroscopy.
22. Murata M, Ware J, Ruggeri ZM: Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ibα demonstrating negatively charged residues Involved in von Willebrand factor binding. J Biol Chem 1991, 266:15474-15480.
23. Marchese P, Murata M, Mazzucato M, Pradella P, De Marco L, Ware J, Ruggeri ZM: Identification of three-tyrosine residues of glycoprotein Ibα with distinct roles in von Willebrand factor and α-thrombin binding. J Biol Chem 1995, 270:9571-9578.
24. Ware J, Russell SR, Marchese P, Murata M, Mazzucato M, De Marco L, Ruggeri ZM: Point mutation In a leucine-rich repeat of platelet glycoprotein Ibα resulting in the Bernard-Soulier syndrome. J Clin Invest 1993, 92:1213-1220.
25. De Marco L, Fabris F, Casonato A, Fabris P, Dal Ben MG, Barbato A, Girolami A: Bernard-Soulier syndrome: diagnosis by an ELISA method using monoclonal antibodies in 2 new unrelated patients. Acta Haematol 1986, 75:203-208.
26. Miller JL, Cunningham D, Lyle VA, Finch CN: Mutation in the gene encoding the a chain of platelet glycoprotein Ib In platelet-type von Willebrand disease. Proc Natl Acad Sci U S A 1991, 88:4761-4765.
27. Miller JL, Castella A: Platelet-type von Willabrand's disease: characterization of a new bleeding disorder. Blood 1982, 60:790-794.
28. Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma J-P, Vicic WJ, Rogers J: Pseudo-von Willebrand's disease: an intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med 1982, 306:326-333.
29. Russell SD, Roth GJ: Pseudo-von Willebrand disease: a mutation in the platelet glycoprotein Ibα gene associated with a hyperactive surface receptor. Blood 1993, 81:1787-1791.
30. Takahashi H, Murata M, Moriki T, Anbo H, Furukawa T, Nikkuni K, Shibata A, Handa M, Kawai Y, Watanabe K, et al.: Substitution of Val for Met at residue 239 of platelet glycoprotein Ibα In Japanese patients with platelet-type von Willebrand disease. Blood 1995, 85:727-733.
31. Miller JL, Lyle VA: Mimotope/anti-mimotope probing of structural relationships in platelet glycoprotein Ibα Proc Natl Acad Sci U S A 1996, 93:3565-3569. Using a bacteriophage library containing random decapeptides, the authors characterize the binding preference of the monoclonal GP Ibα antibody, C34. Other highlights are described in the text.
32. De Marco L, Mazzucato M, Masotti A, Ruggeri ZM: Localization and characterization of an α-thrombin-binding site on platelet glycoprotein Ibα J Biol Chem 1994, 269:6478-6484.
33. Harmon JT, Jamieson GA: The glycocalicin portion of platelet glycoprotein Ib expresses both high and moderate affinity receptor sites for thrombin: a soluble radioreceptor assay for the Interaction of thrombin with platelets. J Biol Chem 1986, 261:13224-13229.
34. Ganguly P: Binding of thrombin to functionally defective platelets: a hypothesis on the nature of the thrombin receptor. Br J Haematol 1977, 37:47-51.
35. Berndt MC, Gregory C, Dowden G, Castaldi PA: Thrombin interactions with platelet membrane proteins. Ann N Y Acad Sci 1986, 485:374-386.
36. Jamieson GA, Okumura T: Reduced thrombin binding and aggregation in Bernard-Soulier platelets. J Clin Invest 1978, 61:861-864.
37. De Marco L, Mazzucato M, Masotti A, Fenton JW, II, Ruggeri ZM: Function of glycoprotein Ibα in platelet activation Induced by α-thrombin. J Biol Chem 1991, 266:23776-23783.
38. Yamamoto N, Greco NJ, Barnard MR, Tanoue K, Yamazaki H, Jamieson GA, Michelson AD: Glycoprotein Ib (GPIb)-dependent and GPIb-independent pathways of thrombin-induced platelet activation. Blood 1991, 77:1740-1748.
39. Harmon JT, Jamieson GA: Platelet activation by thrombin in the absence of the high-affinity thrombin receptor. Biochemistry 1988, 27:2151-2157.
40. Cooper HA, Bennett WP, White GC, II, Wagner RH: Hydrolysis of human platelet membrane glycoproteins with a Serratia marcescens metalloprotease: effect on response to thrombin and von Willebrand factor. Proc Natl Acad Sci U S A 1982, 79:1433-1437.
41. Wicki AN, Clemetson KJ: Structure and function of platelet membrane glycoproteins Ib and V: effects of leukocyte elastase and other proteases on platelets response to von Willebrand factor and thrombin. Eur J Biochem 1985, 153:1-11.
42. 2+ responses of protease-treated human platelets activated with α-thrombin and the tethered ligand peptide. Biochemistry 1996, 35:915-921.
43. Mazurov AV, Vinogradov DV, Vlasik TN, Repin VS, Booth WJ, Berndt MC: Characterization of an antiglycoprotein Ib monoclonal antibody that specifically Inhibits platelet-thrombin interaction. Thromb Res 1991, 62:673-684.
44. 2+] induced by α-thrombin. Biochemistry 1996, 35:906-914. Using monoclonal antibodies and platelets from a patient with Bernard-Soulier syndrome, the authors confirmed that the GP Ib-IX-V complex is the high-affinity binding site for thrombin. The authors suggest that both the GP Ib-IX-V complex and the seven-transmembrane-domain thrombin receptor are required for the optimal rate and extent of platelet activation.
45. Yamamoto K, Yamamoto N, Kitagawa H, Tanoue K, Kosaki G, Yamazaki H: Localization of a thrombin-binding site on human platelet membrane glycoprotein Ib determined by a monoclonal antibody. Thromb Haemost 1986, 55:162-167.
46. Kinlough-Rathbone RL, Perry DW, Packham MA: Contrasting effects of thrombin and the thrombin receptor peptide, SFLLRN, on aggregation and release of 14C-serotonin by human platelets pretreated with chymotrypsin or serratia marcescens protease. Thromb Haemost 1995, 73:122-125.
47. Lasne D, Donato J, Falet H, Rendu F: Different abilities of thrombin receptor activating peptide and thrombin to induce platelet calcium rise and full release reaction. Thromb Haemost 1995, 74:1323-1328.
48. Connolly AJ, Ishihara H, Kahn ML, Farese RVJ, Coughlin SR: Role of the thrombin receptor in development and evidence for a second receptor. Nature 1996, 381:516-519. Platelets from thrombin-receptor knockout mice aggregated normally to thrombin and showed no bleeding tendency.
49. Katagiri Y, Hayashi Y, Yamamoto K, Tanoue K, Kosaki G, Yamazaki H: Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib. Thromb Haemost 1990, 63:122-126.
50. McKeown LP, Williams SB, Hansmann KE, Krutzsch H, Gralnick HR: Glycoprotein Ibα peptides inhibit thrombin and SFLLRN-induced platelet aggregation. J Lab Clin Wed 1996, 128:492-494.
51. Liu L, Freedman J, Hornstein A, Fenton JWI, Song Y, Ofosu FA: Binding of thrombin to the G-protein-linked receptor, and not to glycoprotein Ib, precedes thrombin-mediated platelet activation. J Biol Chem 1996, 272:1997-2004.
52. Kroll MH, Harris TS, Moake JL, Handin RI, Schafer AI: von Willebrand factor binding to platelet GpIb initiates signals for platelet activation. J Clin Invest 1991, 88:1568-1573.
53. Razdan K, Hellums JD, Kroll MH: Shear-stress-induced von Willebrand factor binding to platelets causes the activation of tyrosine kinase(s). Biochem J 1994, 302:681-686.
54. Oda A, Yokoyama K, Murata M, Tokuhira M, Nakamura K, Handa M, Watanabe K, Ikeda Y: Protein tyrosine phosphorylation In human platelet during shear stress-induced platelet aggregation (SIPA) Is regulated by glycoprotein (GP) Ib/IX as well as GP IIb/IIIa and requires intact cytoskeleton and endogenous ADP. Thromb Haemost 1995, 74:736-742.
55. Fujimura Y, Kawasaki T, Titani K: Snake venom proteins modulating the interaction between von Willebrand factor and platelet glycoprotein Ib. Thromb Haemost 1996, 76:633-639. An outstanding review describing the snake venom proteins that modulate the interaction between vWf and the GP Ib-IX-V complex.
56. 2 (14-3-3 protein) with the platelet glycoprotein Ib-IX complex. J Biol Chem 1994, 269:18287-18290.
57. Du X, Fox JE, Pei S: Identification of a binding sequence for the 14-3-3 protein within the cytoplasmic domain of the adhesion receptor, platelet glycoprotein Ibα J Biol Chem 1996, 271:7362-7367. This study identified a binding site for 14-3-3 ζ within a sequence of 15 amino acid residues at the C-terminus of GP Ibα.
58. Braselmann S, McCormick F: Bcr and Raf form a complex in vivo via 14-3-3 proteins. EMBO J 1996, 14:4839-4848.
59. Jones DH, Ley S, Aitken A: Isoforms of 14-3-3 protein can form homo-and heterodimers in vivo and in vitro: implications for function as adapter proteins. FEBS Lett 1996, 368:55-58.
60. Fantl WJ, Muslin AJ, Kikuchi A, Martin JA, MacNicol AM, Gross RW, Williams LT: Activation of Raf-1 by 14-3-3 proteins. Nature 1994, 371:612-614.
61. Meller N, Liu YC, Collins TL, Bonnefoy-Berard N, Baier G, Isakov N, Altman A: Direct interaction between protein kinase Cθ and 14-3 3τ in T cells: 14-3-3 overexpression results in inhibition of PKCθ translocation and function. Mol Cell Biol 1996, 16:5782-5791.
62. Bonnefoy-Berard N, Liu YC, von Willebrand M, Sung A, Elly C, Mustelin T, Yoshida H, Ishizaka K, Altman A: Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins In T cells. Proc Natl Acad Sci U S A 1995, 92:10142-10146.
63. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ: Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996, 87:619-628. Growth factor signals lead to serine phosphorylation of the death agonist BAD. The 14-3-3 protein binds and sequesters the phosphorylated agonist, preventing its association with BCL-X(L), thereby promoting survival.
64. Andrews RK, Fox JE: Identification of a region in the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX complex that binds to purified actin-binding protein. J Biol Chem 1992, 267:18605-18611.
65. Cunningham JG, Meyer SC, Fox JEB: The cytoplasmic domain of the α-subunit of glycoprotein (GP) Ib mediates attachment of the entire GP Ib-IX complex to the cytoskeleton and regulates von Willebrand factor-induced changes in cell morphology. J Biol Chem 1996, 271:11581-11587. Using a series of GP Ibα cytoplasmic truncations, the authors found that the cytoplasmic domain of GP Ibα, through its association with the cytoskeleton, mediated vWF-initiated shape change of cells expressing the GP Ib-IX-V complex.
66. Kovacsovics TJ, Hartwig JH: Thrombin-induced GPIb-IX centralization on the platelet surface requires actin assembly and myosin II activation. Blood 1996, 87:618-629. These studies suggested that thrombin-induced centralization of the GP Ib-IX-V complex required at least two steps, association of the complex and ABP-280 with the cytoskeleton and activation of myosin II. The latter action may provide the force for centralization of the GP Ib-IX-V complex.
67. Meyer SC, Zuerbig S, Cunningham CC, Hartwig JH, Bissell T, Gardner K, Fox JEB: Identification of the region In actin-binding protein that binds to the cytoplasmic domain of glycoprotein Ibα J Biol Chem 1997, 272:2914-2919. These authors used several means to map the site on ABP-280 that interacts with the GP Ib-IX complex.